Sahai, Nikhil
Arunachalam, Dilesh Kumar
Morris, Tim
Copas, Andrew
Samuel, Prasanna
Mohan, Venkata Raghava
Abraham, Vinod
Selwyn, Joshua Anish
Kumar, Praveen
Rose, Winsley
Balaji, Veeraraghavan
Kang, Gagandeep
John, Jacob http://orcid.org/0000-0003-3654-5099
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-036437)
Medical Research Council (MC_UU_00004/07, MC_UU_00004/09, MC_UU_00004/09)
Article History
Received: 5 June 2023
Accepted: 30 July 2023
First Online: 3 August 2023
Declarations
:
: The study proposal was reviewed and approved by India’s Health Ministry Screening Committee (proposal ID 2022–16229, dated 16 March 2022). The protocol was approved by the IRB of CMC Vellore (IRB minutes number 14247, dated 29/09/2021). Any changes or amendments made to the protocol will be submitted to the IRB for approval.Written informed consent will be taken from all adult participants and from the parents of child participants with assent being sought wherever applicable. This will include consent for study staff to review participants’ medical and diagnostic records and store any additional serum samples for future research.
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results.
: The authors declare that they have no competing interests.